$THMO
ThermoGenesis Holdings, Inc.

2020 Q4 Form 10-K Financial Statement

#000143774921006335 Filed on March 17, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 2019 Q4
Revenue $1.950M $9.744M $1.720M
YoY Change 13.37% -25.32% -36.06%
Cost Of Revenue $1.060M $8.485M $1.130M
YoY Change -6.19% 15.43% -39.57%
Gross Profit $890.0K $1.259M $590.0K
YoY Change 50.85% -77.9% -28.05%
Gross Profit Margin 45.64% 12.92% 34.3%
Selling, General & Admin $1.760M $7.677M $3.190M
YoY Change -44.83% -4.43% 36.32%
% of Gross Profit 197.75% 609.77% 540.68%
Research & Development $540.0K $2.477M $640.0K
YoY Change -15.63% 3.38% 42.22%
% of Gross Profit 60.67% 196.74% 108.47%
Depreciation & Amortization $170.0K $742.0K $210.0K
YoY Change -19.05% -7.83% 31.25%
% of Gross Profit 19.1% 58.94% 35.59%
Operating Expenses $2.300M $10.15M $3.830M
YoY Change -39.95% -2.64% 37.28%
Operating Profit -$1.410M -$8.895M -$3.240M
YoY Change -56.48% 87.94% 64.47%
Interest Expense -$1.530M $7.908M -$960.0K
YoY Change 59.38% 76.56% 26.32%
% of Operating Profit
Other Income/Expense, Net $0.00 $5.000K -$10.00K
YoY Change -100.0% -115.15% -125.0%
Pretax Income -$2.950M -$16.73M -$4.200M
YoY Change -29.76% 65.64% -50.99%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.850M -$16.81M -$4.050M
YoY Change -29.63% 66.46% -43.44%
Net Earnings / Revenue -146.15% -172.53% -235.47%
Basic Earnings Per Share
Diluted Earnings Per Share -$359.4K -$2.604M -$1.286M
COMMON SHARES
Basic Shares Outstanding 7.796M 2.844M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.160M $7.160M $3.160M
YoY Change 126.58% 126.58% 31.67%
Cash & Equivalents $7.161M $7.160M $3.157M
Short-Term Investments
Other Short-Term Assets $880.0K $880.0K $1.600M
YoY Change -45.0% -45.0% 627.27%
Inventory $5.877M $5.880M $3.484M
Prepaid Expenses
Receivables $1.382M $1.380M $1.278M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.30M $15.30M $9.521M
YoY Change 60.68% 55.17% 10.38%
LONG-TERM ASSETS
Property, Plant & Equipment $1.424M $2.150M $2.028M
YoY Change -29.78% -25.61% -20.84%
Goodwill $781.0K $781.0K
YoY Change 0.0% 0.0%
Intangibles $1.358M $1.467M
YoY Change -7.43% -7.79%
Long-Term Investments $10.00K
YoY Change 0.0%
Other Assets $48.00K $1.260M $218.0K
YoY Change -77.98% 500.0% 327.45%
Total Long-Term Assets $5.562M $5.560M $5.693M
YoY Change -2.3% 3.93% -4.88%
TOTAL ASSETS
Total Short-Term Assets $15.30M $15.30M $9.521M
Total Long-Term Assets $5.562M $5.560M $5.693M
Total Assets $20.86M $20.86M $15.21M
YoY Change 37.11% 37.15% 4.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.366M $1.370M $1.447M
YoY Change -5.6% -5.52% -40.28%
Accrued Expenses $2.430M $2.430M $2.160M
YoY Change 12.5% 12.5% -2.7%
Deferred Revenue $608.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $450.0K $450.0K
YoY Change
Total Short-Term Liabilities $6.143M $6.140M $6.685M
YoY Change -8.11% -8.22% 5.03%
LONG-TERM LIABILITIES
Long-Term Debt $6.630M $6.630M $4.930M
YoY Change 34.48% 34.48% 321.37%
Other Long-Term Liabilities $20.00K $2.220M $20.00K
YoY Change 0.0% -17.16% -47.37%
Total Long-Term Liabilities $20.00K $8.850M $20.00K
YoY Change 0.0% 16.29% -47.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.143M $6.140M $6.685M
Total Long-Term Liabilities $20.00K $8.850M $20.00K
Total Liabilities $14.99M $15.06M $14.30M
YoY Change 4.84% 1.55% 81.45%
SHAREHOLDERS EQUITY
Retained Earnings -$253.3M -$236.9M
YoY Change 6.9% 4.18%
Common Stock $9.000K $3.000K
YoY Change 200.0% 50.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.800M $5.800M $386.0K
YoY Change
Total Liabilities & Shareholders Equity $20.86M $20.86M $15.21M
YoY Change 37.11% 37.15% 4.13%

Cashflow Statement

Concept 2020 Q4 2020 2019 Q4
OPERATING ACTIVITIES
Net Income -$2.850M -$16.81M -$4.050M
YoY Change -29.63% 66.46% -43.44%
Depreciation, Depletion And Amortization $170.0K $742.0K $210.0K
YoY Change -19.05% -7.83% 31.25%
Cash From Operating Activities -$2.530M -$14.39M $260.0K
YoY Change -1073.08% 341.5% -42.22%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $23.00K $0.00
YoY Change -87.36% -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$23.00K $0.00
YoY Change -87.36% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.260M $17.42M 100.0K
YoY Change 5160.0% 314.91% -600.0%
NET CHANGE
Cash From Operating Activities -2.530M -$14.39M 260.0K
Cash From Investing Activities 0.000 -$23.00K 0.000
Cash From Financing Activities 5.260M $17.42M 100.0K
Net Change In Cash 2.730M $3.004M 360.0K
YoY Change 658.33% 296.83% 100.0%
FREE CASH FLOW
Cash From Operating Activities -$2.530M -$14.39M $260.0K
Capital Expenditures $0.00 $23.00K $0.00
Free Cash Flow -$2.530M -$14.42M $260.0K
YoY Change -1073.08% 318.83% -62.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0000811212
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11911784
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q2 dei Entity Public Float
EntityPublicFloat
27692000
CY2020 dei Entity Registrant Name
EntityRegistrantName
ThermoGenesis Holdings, Inc.
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
true
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2020 dei Trading Symbol
TradingSymbol
thmo
CY2019 thmo Adjustments To Additional Paid In Capital Exercise Of Prefunded Warrants
AdjustmentsToAdditionalPaidInCapitalExerciseOfPrefundedWarrants
42000
CY2020 thmo Adjustments To Additional Paid In Capital Exercise Of Prefunded Warrants
AdjustmentsToAdditionalPaidInCapitalExerciseOfPrefundedWarrants
32000
CY2019Q4 thmo Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1646214
CY2020Q4 thmo Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1046631
CY2019Q4 thmo Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights
22.91
CY2020Q4 thmo Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights
34.42
CY2019 thmo Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P1Y229D
thmo Class Of Warrant Or Right Exercisable Weighted Average Remaining Contract Term
ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractTerm
P197D
CY2019 thmo Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
435264
thmo Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
599582
CY2019 thmo Class Of Warrant Or Right Exercised During Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodWeightedAverageExercisePrice
0.35
thmo Class Of Warrant Or Right Exercised During Period Weighted Average Exercise Price
ClassOfWarrantOrRightExercisedDuringPeriodWeightedAverageExercisePrice
2.81
CY2019 thmo Class Of Warrant Or Right Expired Or Cancelled During Period
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
19637
thmo Class Of Warrant Or Right Expired Or Cancelled During Period
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
CY2019 thmo Class Of Warrant Or Right Expired Or Cancelled During Period Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodWeightedAverageExercisePrice
thmo Class Of Warrant Or Right Expired Or Cancelled During Period Weighted Average Exercise Price
ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodWeightedAverageExercisePrice
CY2019 thmo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
444445
thmo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
CY2019 thmo Class Of Warrant Or Right Issued During Period Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodWeightedAverageExercisePrice
0.10
thmo Class Of Warrant Or Right Issued During Period Weighted Average Exercise Price
ClassOfWarrantOrRightIssuedDuringPeriodWeightedAverageExercisePrice
CY2018 thmo Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P2Y73D
CY2019 thmo Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P1Y208D
thmo Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P1Y208D
thmo Class Of Warrant Or Right Outstanding Weighted Average Remaining Contract Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractTerm
P178D
CY2018Q4 thmo Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
29.88
CY2019Q4 thmo Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
25.23
CY2020Q4 thmo Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights
37.27
CY2020Q4 thmo Deferred Tax Assets Lease Obligation
DeferredTaxAssetsLeaseObligation
160000
CY2019Q4 thmo Deferred Tax Assets Lease Obligation
DeferredTaxAssetsLeaseObligation
185000
CY2020Q4 thmo Deferred Tax Liabilities Lease Asset
DeferredTaxLiabilitiesLeaseAsset
153000
CY2019Q4 thmo Deferred Tax Liabilities Lease Asset
DeferredTaxLiabilitiesLeaseAsset
180000
CY2020 thmo Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount
EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount
1619000
CY2019 thmo Effective Income Tax Rate Reconciliation Disallowed Financing Costs Amount
EffectiveIncomeTaxRateReconciliationDisallowedFinancingCostsAmount
1119000
CY2020 thmo Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses Amount
EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAmount
1558000
CY2019 thmo Effective Income Tax Rate Reconciliation Expiration Of Net Operating Losses Amount
EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingLossesAmount
1187000
CY2020 thmo Effective Income Tax Rate Reconciliation Intangible Assets Amount
EffectiveIncomeTaxRateReconciliationIntangibleAssetsAmount
69000
CY2019 thmo Effective Income Tax Rate Reconciliation Intangible Assets Amount
EffectiveIncomeTaxRateReconciliationIntangibleAssetsAmount
673000
CY2020 thmo Fair Value Of Amended Convertible Note Issued
FairValueOfAmendedConvertibleNoteIssued
CY2019 thmo Fair Value Of Amended Convertible Note Issued
FairValueOfAmendedConvertibleNoteIssued
1473000
CY2020 thmo Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities
IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities
-456000
CY2019 thmo Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities
IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities
1492000
CY2019 thmo Intangible Assets Net Excluding Goodwill Amortization And Foreign Currency Translation Gain Loss
IntangibleAssetsNetExcludingGoodwillAmortizationAndForeignCurrencyTranslationGainLoss
124000
CY2020 thmo Intangible Assets Net Excluding Goodwill Amortization And Foreign Currency Translation Gain Loss
IntangibleAssetsNetExcludingGoodwillAmortizationAndForeignCurrencyTranslationGainLoss
109000
CY2020Q4 thmo Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
2082000
CY2019Q4 thmo Interest Payable Related Party Current
InterestPayableRelatedPartyCurrent
1869000
CY2020 thmo Inventory Change In Reserve
InventoryChangeInReserve
3308000
CY2019 thmo Inventory Change In Reserve
InventoryChangeInReserve
92000
CY2020 thmo Nonoperating Income Expense Including Interest Expense
NonoperatingIncomeExpenseIncludingInterestExpense
-7916000
CY2019 thmo Nonoperating Income Expense Including Interest Expense
NonoperatingIncomeExpenseIncludingInterestExpense
-5366000
CY2020 thmo Operating Lease Interest Expense
OperatingLeaseInterestExpense
182000
CY2019 thmo Operating Lease Interest Expense
OperatingLeaseInterestExpense
204000
CY2020 thmo Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
10839000
CY2019 thmo Proceeds From Issuance Of Common Stock Net
ProceedsFromIssuanceOfCommonStockNet
756000
CY2020 thmo Recording Of Beneficial Conversion Feature On Debt
RecordingOfBeneficialConversionFeatureOnDebt
4981000
CY2019 thmo Recording Of Beneficial Conversion Feature On Debt
RecordingOfBeneficialConversionFeatureOnDebt
2313000
CY2019 thmo Reorganization Of Subsidiary And Related Change In Noncontrolling Interest
ReorganizationOfSubsidiaryAndRelatedChangeInNoncontrollingInterest
CY2020 thmo Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeitures And Expirations Intrinsic Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresAndExpirationsIntrinsicValue
1840
CY2020Q3 thmo Short Term Investment Minimum
ShortTermInvestmentMinimum
1000000
CY2019 thmo Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
112000
CY2020 thmo Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
1651000
CY2020 thmo Transfer Of Equipment To Inventories
TransferOfEquipmentToInventories
CY2019 thmo Transfer Of Equipment To Inventories
TransferOfEquipmentToInventories
44000
CY2020 thmo Transfer Of Inventories To Equipment
TransferOfInventoriesToEquipment
CY2019 thmo Transfer Of Inventories To Equipment
TransferOfInventoriesToEquipment
22000
CY2020Q4 thmo Working Capital
WorkingCapital
9155000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1366000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1447000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1382000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1278000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6399000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5898000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
16000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
259058000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
237313000
CY2019 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
2313000
CY2020 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
4981000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
614000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
880000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
880000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
614000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
214000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
226000
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5558000
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2349000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
109000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
124000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9307017
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8367074
CY2020Q4 us-gaap Assets
Assets
20860000
CY2019Q4 us-gaap Assets
Assets
15214000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
15298000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
9521000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7161000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3157000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4157000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3400000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7161000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3004000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
757000
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1726522
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1716066
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1116484
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
620000
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1049000
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
493000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8934952
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2843601
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8934952
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2843601
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16337000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9482000
CY2020 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-460000
CY2019 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-602000
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-16797000
CY2019 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10084000
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Credit Risk</div></div></div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Currently, the Company primarily manufactures and sells cellular processing systems and thermodynamic devices principally to the blood and cellular component processing industry and performs ongoing evaluations of the credit worthiness of the Company's customers. The Company believes that adequate provisions for uncollectible accounts have been made in the accompanying consolidated financial statements. To date, the Company has <div style="display: inline; font-style: italic; font: inherit;">not</div> experienced significant credit related losses.</div></div></div></div></div>
CY2019Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
413000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8485000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7351000
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3368000
CY2019 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
432000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
507000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
46000
CY2020Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
5935000
CY2019Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
3518000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.60
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
505000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
588000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
608000
CY2019Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
620000
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1596000
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1901000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
340000
CY2019Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
419000
CY2020Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
369000
CY2019Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
384000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31561000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
31446000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27312000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
26758000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
528000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
943000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2852000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
2757000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
31056000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30858000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
352000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
408000
CY2020 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
147000
CY2019 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
0
CY2020 us-gaap Depreciation
Depreciation
516000
CY2019 us-gaap Depreciation
Depreciation
574000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
742000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
805000
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
CY2019 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.36
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
349000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
288000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
33000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
24000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1095000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
993000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
47000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
40000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
32000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
32000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
32000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
32000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1310000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1317000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
215000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
324000
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-118000
CY2019 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-70000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-840000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5729000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6377000
CY2018Q4 us-gaap Goodwill
Goodwill
781000
CY2019Q4 us-gaap Goodwill
Goodwill
781000
CY2020Q4 us-gaap Goodwill
Goodwill
781000
CY2019 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
355000
CY2019 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
CY2020 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
CY2020 us-gaap Gross Profit
GrossProfit
1259000
CY2019 us-gaap Gross Profit
GrossProfit
5696000
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2019 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-16728000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-9949000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-83000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-150000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-13000
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-15000
CY2020Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
197000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-681000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3530000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2118000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
105000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
25000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-18000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-205000
CY2020 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-76000
CY2019 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-966000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
90000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-301000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-12000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
135000
CY2020 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
213000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
310000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
61000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-415000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6582000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-610000
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1128000
CY2019 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1143000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
106000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
525000
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2453000
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
2460000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1358000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1467000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1591000
CY2020 us-gaap Interest Expense
InterestExpense
7908000
CY2019 us-gaap Interest Expense
InterestExpense
4479000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
2379000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
177000
CY2020Q4 us-gaap Inventory Net
InventoryNet
5877000
CY2019Q4 us-gaap Inventory Net
InventoryNet
3484000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
1221000
CY2019Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
340000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1096000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
730000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
859000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
139000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
328000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
319000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
335000
CY2020Q4 us-gaap Liabilities
Liabilities
14990000
CY2019Q4 us-gaap Liabilities
Liabilities
14298000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20860000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15214000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6143000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6685000
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
199000
CY2019Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1000000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
70000
CY2019Q4 us-gaap Minority Interest
MinorityInterest
530000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17422000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4199000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-182000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14393000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3260000
CY2020 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-460000
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-602000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16351000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9497000
CY2019 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-10099000
CY2020 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-16811000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
447000
CY2019Q4 us-gaap Notes Payable Current
NotesPayableCurrent
CY2020 us-gaap Operating Expenses
OperatingExpenses
10154000
CY2019 us-gaap Operating Expenses
OperatingExpenses
10429000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-8895000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-4733000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
450000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
410000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
761000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
604000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
761000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
301000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
291000
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
129000
CY2019 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
108000
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.22
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.22
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y146D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y146D
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
218000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1291000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2461000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-33000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
182000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
878000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
602000
CY2020 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Reclassifications</div></div></div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did <div style="display: inline; font-style: italic; font: inherit;">not</div> have an impact on net loss as previously reported.</div></div></div></div></div>
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4287000
CY2019 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1800000
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
646000
CY2019 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2019 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1513000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1683000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
154000
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
277000
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
186000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
154000
CY2020 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
212000
CY2019 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
154000
CY2020 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
18000
CY2019 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-9000
CY2020 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
71000
CY2019 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
254000
CY2020 us-gaap Profit Loss
ProfitLoss
-16811000
CY2019 us-gaap Profit Loss
ProfitLoss
-10099000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7823000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7926000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1424000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2028000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-12000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-60000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
451000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
384000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
338000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4391000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2477000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2396000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
1000000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-253283000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-236932000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
9705000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
12160000
CY2020 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
39000
CY2019 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
887000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1534000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
973000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
711000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5870000
CY2020 us-gaap Revenues
Revenues
9744000
CY2019 us-gaap Revenues
Revenues
13047000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
966000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.16
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.03
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1948000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1656000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
880000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
614000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0054
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0168
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
230836
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.21
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
17671
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
565500
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
615500
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.05
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.30
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
280000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
291807
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
889636
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.96
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.57
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
598092
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.72
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.63
CY2020Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.94
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.92
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y182D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y109D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y255D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y182D
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
28000
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
26000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
432000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
368000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
756000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10839000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5800000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
386000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6731000
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
916000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div></div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) and requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, but <div style="display: inline; font-style: italic; font: inherit;">not</div> limited to, the allowance for doubtful accounts, carrying amounts of inventories, depreciation and amortization, warranty obligations, assumptions made in valuing financial instruments issued in various compensation and financing arrangements, deferred income taxes and related valuation allowance and the fair values of intangibles and goodwill. Actual results could materially differ from the estimates and assumptions used in the preparation of the Company's consolidated financial statements.</div></div></div></div></div>
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
197000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-681000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
111000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
72000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6277986
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2828606

Files In Submission

Name View Source Status
0001437749-21-006335-index-headers.html Edgar Link pending
0001437749-21-006335-index.html Edgar Link pending
0001437749-21-006335.txt Edgar Link pending
0001437749-21-006335-xbrl.zip Edgar Link pending
ex_233812.htm Edgar Link pending
ex_233813.htm Edgar Link pending
ex_233814.htm Edgar Link pending
ex_233815.htm Edgar Link pending
ex_234739.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
logo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thmo-20201231.xml Edgar Link completed
thmo-20201231.xsd Edgar Link pending
thmo-20201231_cal.xml Edgar Link unprocessable
thmo-20201231_def.xml Edgar Link unprocessable
thmo-20201231_lab.xml Edgar Link unprocessable
thmo-20201231_pre.xml Edgar Link unprocessable
thmo20201231_10k.htm Edgar Link pending